Research article

Alcohol consumption and HIV disease prognosis among virally unsuppressed in Rural KwaZulu Natal, South Africa

  • Received: 17 March 2023 Revised: 19 July 2023 Accepted: 25 July 2023 Published: 16 August 2023
  • Background 

    The effect of alcohol consumption and human immunodeficiency virus (HIV) disease prognosis has been examined in several studies with inconsistent findings. We sought to determine the effect of alcohol consumption on HIV disease prognosis by examining CD4+ T cell count/µL (CD4+ count) and HIV RNA concentration [HIV viral load (VL)] independent of anti-retroviral therapy (ART).

    Methods 

    A secondary analysis was performed on a cross-sectional survey data of 1120 participants between 2018 and 2020. Questionnaires were used to obtain the participants' history of alcohol consumption. Blood samples were assayed for CD4+ T cell count/µL (CD4+ count) and HIV RNA concentration (HIV viral load). The history of alcohol consumption was categorized into non-alcohol consumers, non-heavy alcohol consumers, and heavy-alcohol consumers. Age, cigarette smoking, gender, and ART use were considered potential confounders. Participants were categorized into two cohorts for the analysis and a multivariate logistic regression was used to establish relationships among virally unsuppressed participants who were ART-experienced and ART-naïve.

    Results 

    A total of 1120 participants were considered for analysis. The majority were females (65.9%) between 15–39 years (72.4%). The majority were non-smokers and non-alcohol consumers (88% and 79%, respectively). ART-experienced females had an increased risk of having a higher VL (VL > 1000). This finding was statistically significant [RR, 0.425, 95% CI, (0.192–0.944), p-value, 0.036]. However, ART-experienced participants aged above 64 years had an increased risk of having a lower VL (VL < 1000 copies/mL) and a lower risk of having a higher VL (VL > 1000). However, ART-naïve participants aged between 40–64 years had a significantly lower risk of having higher CD4 count (CD4+ > 500 cells) and an increased risk of having a lower CD4 count [OR, 0.566 95% CI, (0.386–0.829), p-value, 0.004]. History of alcohol consumption did not have a significant effect on CD4+ cell count and VL in neither the ART-experienced nor the naïve cohort.

    Conclusions 

    Female middle-aged people living with HIV (PLWH) are more likely to have a poorer HIV disease state, independent of alcohol consumption. Alcohol consumption may not have a direct effect on CD4+ cell count and VL in either ART-naïve or experienced patients.

    Citation: Manasseh B. Wireko, Jacobus Hendricks, Kweku Bedu-Addo, Marlise Van Staden, Emmanuel A. Ntim, Samuel F. Odoom, Isaac K. Owusu. Alcohol consumption and HIV disease prognosis among virally unsuppressed in Rural KwaZulu Natal, South Africa[J]. AIMS Medical Science, 2023, 10(3): 223-236. doi: 10.3934/medsci.2023018

    Related Papers:

  • Background 

    The effect of alcohol consumption and human immunodeficiency virus (HIV) disease prognosis has been examined in several studies with inconsistent findings. We sought to determine the effect of alcohol consumption on HIV disease prognosis by examining CD4+ T cell count/µL (CD4+ count) and HIV RNA concentration [HIV viral load (VL)] independent of anti-retroviral therapy (ART).

    Methods 

    A secondary analysis was performed on a cross-sectional survey data of 1120 participants between 2018 and 2020. Questionnaires were used to obtain the participants' history of alcohol consumption. Blood samples were assayed for CD4+ T cell count/µL (CD4+ count) and HIV RNA concentration (HIV viral load). The history of alcohol consumption was categorized into non-alcohol consumers, non-heavy alcohol consumers, and heavy-alcohol consumers. Age, cigarette smoking, gender, and ART use were considered potential confounders. Participants were categorized into two cohorts for the analysis and a multivariate logistic regression was used to establish relationships among virally unsuppressed participants who were ART-experienced and ART-naïve.

    Results 

    A total of 1120 participants were considered for analysis. The majority were females (65.9%) between 15–39 years (72.4%). The majority were non-smokers and non-alcohol consumers (88% and 79%, respectively). ART-experienced females had an increased risk of having a higher VL (VL > 1000). This finding was statistically significant [RR, 0.425, 95% CI, (0.192–0.944), p-value, 0.036]. However, ART-experienced participants aged above 64 years had an increased risk of having a lower VL (VL < 1000 copies/mL) and a lower risk of having a higher VL (VL > 1000). However, ART-naïve participants aged between 40–64 years had a significantly lower risk of having higher CD4 count (CD4+ > 500 cells) and an increased risk of having a lower CD4 count [OR, 0.566 95% CI, (0.386–0.829), p-value, 0.004]. History of alcohol consumption did not have a significant effect on CD4+ cell count and VL in neither the ART-experienced nor the naïve cohort.

    Conclusions 

    Female middle-aged people living with HIV (PLWH) are more likely to have a poorer HIV disease state, independent of alcohol consumption. Alcohol consumption may not have a direct effect on CD4+ cell count and VL in either ART-naïve or experienced patients.



    加载中

    Acknowledgments



    We acknowledge that the data received from AHRI enabled us to perform this secondary analysis. We are very grateful to the Vukuzazi team members for their technical assistance in interpreting some of the variables used in the dataset.

    Authors' contributions



    All authors made a significant contribution to this study, whether that is in conception, data analysis and interpretation. All authors also took part in the drafting, revising, and gave approval for the publication of this manuscript.

    Use of AI tools declaration



    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    Conflict of interest



    Authors involved in this study have no conflict of interest to declare.

    [1] UNAIDS, UNAIDS DATA 2022. Switzerland UNAIDS, 2022. Available from: unaids.org/sites/default/files/media_asset/data-book-2022_en.pdf
    [2] Jahagirdar D, Walters MK, Novotney A, et al. (2021) Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019. Lancet HIV 8: e633-e651. https://doi.org/10.1016/S2352-3018(21)00152-1
    [3] UNAIDS, UNAIDS data 2021. Switzerland UNAIDS, 2021. Available from: https://www.unaids.org/sites/default/files/media_asset/JC3032_AIDS_Data_book_2021_En.pdf
    [4] Woolf-King SE, Fatch R, Cheng DM, et al. (2018) Alcohol use and unprotected sex among HIV-infected Ugandan adults: findings from an event-level study. Arch Sex Behav 47: 1937-1848. https://doi.org/10.1007/s10508-017-1131-1
    [5] Muyindike WR, Lloyd-travaglini C, Fatch R, et al. (2017) Phosphatidylethanol confirmed alcohol use among ART-naïve HIV-infected persons who denied consumption in rural Uganda. AIDS Care 29: 1442-1447. https://doi.org/10.1080/09540121.2017.1290209
    [6] Kiwanuka N, Ssetaala A, Ssekandi I, et al. (2017) Population attributable fraction of incident HIV infections associated with alcohol consumption in fishing communities around Lake Victoria, Uganda. PLoS One 12: e0171200. https://doi.org/10.1371/journal.pone.0171200
    [7] Eyawo O, McGinnis KA, Justice AC, et al. (2018) Alcohol and mortality: combining self-reported (AUDIT-C) and biomarker detected (PEth) alcohol measures among HIV infected and uninfected. J Acquir Immune Defic Syndr 77: 135-143. https://doi.org/10.1097/QAI.0000000000001588
    [8] Magidson JF, Fatch R, Orrell C, et al. (2019) Biomarker-measured unhealthy alcohol use in relation to CD4 count among individuals starting ART in Sub-Saharan Africa. AIDS Behav 23: 1656-1667. https://doi.org/10.1007/s10461-018-2364-2
    [9] Baum MK, Rafie C, Lai S, et al. (2010) Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses 26: 511-518. https://doi.org/10.1089/aid.2009.0211
    [10] Samet JH, Cheng DM, Libman H, et al. (2007) Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr 46: 194-199. https://doi.org/10.1097/QAI.0b013e318142aabb
    [11] Hahn JA, Samet JH (2010) Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep 7: 226-233. https://doi.org/10.1007/s11904-010-0060-6
    [12] Wandera B, Tumwesigye NM, Nankabirwa JI, et al. (2017) Efficacy of a single, brief alcohol reduction intervention among men and women living with HIV/AIDS and using alcohol in Kampala, Uganda: A randomized trial. J Int Assoc Provid AIDS Care 16: 276-285. https://doi.org/10.1177/2325957416649669
    [13] Hahn JA, Cheng DM, Emenyonu NI, et al. (2018) Alcohol use and HIV disease progression in an antiretroviral naive cohort. J Acquir Immune Defic Syndr 77: 492-501. https://doi.org/10.1097/QAI.0000000000001624
    [14] Bryant KJ, Nelson S, Braithwaite RS, et al. (2010) Integrating HIV/AIDS and alcohol research. Alcohol Res Health 33: 167-178.
    [15] Amedee A, Nichols W, Robichaux S, et al. (2014) Chronic alcohol abuse and HIV disease progression: studies with the non-human primate model. Curr HIV Res 12: 243-253. https://doi.org/10.2174/1570162x12666140721115717
    [16] Molina PE, Bagby GJ, Nelson S (2014) Biomedical consequences of alcohol use disorders in the HIV-infected host. Curr HIV Res 12: 265-275. https://doi.org/10.2174/1570162x12666140721121849
    [17] Talman A, Bolton S, Walson JL (2013) Interactions between HIV/AIDS and the environment: toward a syndemic framework. Am J Public Health 103: 253-261. https://doi.org/10.2105/AJPH.2012.300924
    [18] Massyn N, Barron P, Day C, et al. (2020) District Health Baromether 2018/2019. Durban: Health Systems Trust.
    [19] Gunda R, Koole O, Gareta D, et al. (2022) Cohort profile: the Vukuzazi (“Wake Up and Know Yourself” in isiZulu) population science programme. Int J Epidemiol 51: e131-e142. https://doi.org/10.1093/ije/dyab229
    [20] World Health Organization, WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children.  World Health Organization, 2007. Available from: https://apps.who.int/iris/handle/10665/43699
    [21] Neuman MG, Schneider M, Nanau RM, et al. (2012) Alcohol consumption, progression of disease and other comorbidities, and responses to antiretroviral medication in people living with HIV. AIDS Res Treat 2012: 751827. https://doi.org/10.1155/2012/751827
    [22] Marshall BDL, Tateb JP, McGinnis KA, et al. (2017) Long-term alcohol use patterns and HIV disease severity. AIDS 31: 1313-1321. https://doi.org/10.1097/QAD.0000000000001473
    [23] Wu ES, Metzger DS, Lynch KG, et al. (2011) Association betwwn alcohol use and HIV viral load. J Acquir Immune Defic Syndr 56: e129-130. https://doi.org/10.1097/QAI.0b013e31820dc1c8
    [24] da Silva CM, Mendoza-Sassi RA, da Mota LD, et al. (2017) Alcohol use disorders among people living with HIV/AIDS in Southern Brazil: prevalence, risk factors and biological markers outcomes. BMC Infect Dis 17: 263. https://doi.org/10.1186/s12879-017-2374-0
    [25] Ghebremichaela M, Paintsil E, Ickovicsc JR, et al. (2009) Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. AIDS Care 21: 834-841. https://doi.org/10.1080/09540120802537864
    [26] Carrico AW, Hunt PW, Emenyonu NI, et al. (2015) Unhealthy alcohol use is associated with monocyte activation prior to starting anti-retroviral therapy. Alcohol Clin Exp Res 39: 2422-2426. https://doi.org/10.1111/acer.12908
    [27] Sureshchandra S, Raus A, Jankeel A, et al. (2019) Dose-dependent effects of chronic alcohol drinking on peripheral immune responses. Sci Rep 9: 7847. https://doi.org/10.1038/s41598-019-44302-3
    [28] Dasarathy S (2016) Nutrition and alcoholic liver disease: effects of alcoholism on nutrition, effects of nutrition on alcoholic liver disease and nutritional therapies for alcoholic liver disease. Clin Liver Dis 20: 535-550. https://doi.org/10.1016/j.cld.2016.02.010
    [29] Langford SE, Ananworanich J, Cooper DA (2007) Predictors of disease progression in HIV infection: A review. AIDS Res Ther 4: 1-14. https://doi.org/10.1186/1742-6405-4-11
    [30] Manfredi R (2002) HIV disease and advanced age: An increasing therapeutic challenge. Drugs Aging 19: 647-669. https://doi.org/10.2165/00002512-200219090-00003
    [31] Klimas N, Koneru AOB, Fletcher MA (2008) Overview of HIV. Psychosom Med 70: 523-530. https://doi.org/10.1097/PSY.0b013e31817ae69f
    [32] Kalichman SC, Pellowski J, Turner C (2011) Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect 87: 183-190. https://doi.org/10.1136/sti.2010.047514
    [33] Abaasa A, Crook A, Gafos M, et al. (2013) Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda. Trials 14: 33. https://doi.org/10.1186/1745-6215-14-33
    [34] Abbai NS, Wand H, Ramjee G (2016) Biological factors that place women at risk for HIV: evidence from a large-scale clinical trial in Durban. BMC Womens Health 16: 19. https://doi.org/10.1186/s12905-016-0295-5
    [35] Rogers RG, Everett BG, Onge JMS, et al. (2010) Social, behavioral, and biological factors, and sex differences in mortality. Demography 47: 555-78. https://doi.org/10.1353/dem.0.0119
  • Reader Comments
  • © 2023 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(1205) PDF downloads(130) Cited by(1)

Article outline

Figures and Tables

Tables(7)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog